Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Ask The Experts-Adhesives Bonding

September 1, 2010 11:44 am | by Kyle Rhodes | Blogs | Comments

Question: Our tube set application uses a nylon tube bonded to a clear urethane tube, with a bond gap overlap of 0.010 inch x 0.004 inch thick bond gap. We have been looking at a DYMAX medical grade light-curable adhesive to bond the tube sets and get good adhesion, but we found that during our manufacturing run, some of the adhesive gets pushed inside the opaque nylon tube, and does not cure. Will this material cure by itself over time?

InfraReDx heart device gets FDA marketing approval

September 1, 2010 11:39 am | by Mass High Tech: The Journal of New England Technology | News | Comments

InfraReDx Inc., a Burlington-based medical device firm, has been granted clearance from the U.S. Food and Drug Administration to market its LipiScan IVUS Coronary Imaging System.

TOPICS:

ESHRE's first workshop in Croatia: 'The determinants of a successful pregnancy'

September 1, 2010 11:39 am | by EurekAlert | News | Comments

(European Society of Human Reproduction and Embryology) The European Society of Human Reproduction and Embryology Special Interest Groups Reproductive Surgery, Early Pregnancy and Reproductive Endocrinology invite you to this campus course where scientists and clinicians will...

TOPICS:
Advertisement

ISM manufacturing index picks up to 56.3%

September 1, 2010 11:37 am | by Material Handling Industry of America | News | Comments

U.S. manufacturing picked up its growth pace for the first time in four months, the Institute for Supply Management (ISM) reported. The ISM index rose to 56.3% in August from 55.5% in July. This was much stronger than expected."Manufacturing activity

European Interspinous Process Decompression Device Market Will Grow Nominally at 1.2% over the Next Five Years

September 1, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

TORONTO, Sept. 1 / - According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, although interspinous process decompression devices will continue to be used in a narrow set of indications over the next five years in Europe, the market...

TOPICS:

Varian Medical Systems Establishes Radiotherapy Training Center in Mumbai, India

September 1, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

MUMBAI, India, Sept. 1 /- Varian Medical Systems (NYSE: VAR ), a world leader in radiotherapy equipment and software, has established its first education center in India to train medical physicists and technologists working on the company's advanced cancer treatment systems. The center in...

TOPICS:

U.S. Court of Appeals Upholds Validity of Lilly's Evista Patents Through March of 2014

September 1, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, Sept. 1 /- Eli Lilly and Company (NYSE: LLY ) today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a prior ruling by the U.S. District Court for the Southern District of Indiana that the company's method-of-use patents for Evista®...

TOPICS:

The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting Regarding Bevacizumab in Advanced Breast Cancer

September 1, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

COLD SPRING HARBOR, N.Y., Sept. 1 /- The ASCO Post captured initial reactions to the Oncologic Drugs Advisory Committee (ODAC) recommendation that the breast cancer indication for bevacizumab (Avastin) be revoked in interviews with ODAC voting members, breast cancer specialists,...

TOPICS:
Advertisement

QRxPharma Announces Interim Analysis of Final Pivotal Phase 3 Study for MoxDuo®IR

September 1, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

SYDNEY, Australia and BEDMINSTER, N.J., Sept. 1 /- QRxPharma (ASX: QRX and OTCQX: QRXPY) announced today a successful interim analysis of its final MoxDuo IR pivotal Phase 3 study required for New Drug Application (NDA) submission. The analysis indicated the planned sample size of 140...

TOPICS:

NCPA Launches www.PharmacyMatching.com to Connect Independent Pharmacy Buyers and Sellers

September 1, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

ALEXANDRIA, Va., Sept. 1 /PRNewswire-USNewswire/ -- The National Community Pharmacists Association today announced the launch of a new website, www.PharmacyMatching.com to bring together independent pharmacy owners preparing to sell their pharmacy, existing owners who desire additional...

TOPICS:

Radiation Oncology Services of America, Inc. to Work With Washington University on Quality Assurance Initiative

September 1, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

NASHVILLE, Tenn., Sept. 1 /- Radiation Oncology Services of America, Inc. (ROSA), a subsidiary of Ambulatory Services of America, Inc. (ASA), announced today that it has entered into an agreement with the Department of Radiation Oncology at the Washington University in St. Louis School of...

TOPICS:

MedWOW Adds Comparison Tool for Shoppers' Medical Equipment - Offers eBook Free to New Registrants

September 1, 2010 11:36 am | by Bio-Medicine.Org | News | Comments

NICOSIA, Cyprus, Sept. 1 /- MedWOW.com, the global online marketplace for medical equipment , is pleased to announce the addition of its newest consumer-focused tool: a comparison feature that allows buyers to select as many items as they would like to compare, assisting them in making...

TOPICS:

Volunteers needed for calorie consumption and exercise study

September 1, 2010 11:35 am | by Baylor College of Medicine | News | Comments

The USDA/ARS Children's Nutrition Research Center at Baylor College of Medicine is recruiting volunteers to participate in a two-visit study for healthy 3- to 5 -year-olds. The purpose of the study is to develop a method to determine calories used in young children by having them wear...

TOPICS:

Unilife Corporation Secures FDA 510k Clearance for the Unitract™ 1mL Tuberculin Syringe

September 1, 2010 11:35 am | by Bio-Medicine.Org | News | Comments

LEWISBERRY, Pa., Sept. 1 /- Unilife Corporation ("Unilife" or "Company") (Nasdaq: UNIS, ASX: UNS), today announced that its Unitract™ Tuberculin (TB) Syringe has received  510(k) market clearance from the U.S. Food and Drug Administration (FDA).   The Unitract™ TB...

TOPICS:

Metformin May Protect Against Lung Cancer

September 1, 2010 11:33 am | by AACR | News | Comments

PHILADELPHIA — Metformin, a drug commonly used to treat type 2 diabetes, shows potential in the prevention of tobacco-induced lung tumors, according to early research conducted at the National Cancer Institute (NCI).

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading